Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preoperative FOLFOX-based Therapy for Colorectal Liver Metastases
NCT00537823Phase 2Terminated
- Sponsor
- Washington University School of Medicine
- Start
- Jun 2007
- Primary completion
- Dec 2009
- Modality
- Antibody Conjugates, Monoclonal Antibodies, DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of cetuximab, bevacizumab, oxaliplatin, fluorouracil in colorectal cancer (CRC), sponsored by Washington University School of Medicine. Started Jun 2007; status: terminated.
02
Drugs
cetuximabbevacizumaboxaliplatinfluorouracil
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT00537823.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00537823.